RACHAEL SHUMAKER: Open Payments
NPI 1689263113 · CANTONMENT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 16 payments from 7 companies in 2025. Trend: 2023 $206 · 2024 $174 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $71 |
| Novo Nordisk Inc | 4 | $68 |
| ABBVIE INC. | 2 | $57 |
| SHIELD THERAPEUTICS INC | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| PFIZER INC. | 1 | $18 |
Products named: ACCRUFER, REPATHA, OTEZLA, CAPLYTA, Ozempic, QULIPTA, UBRELVY, RELISTOR.
Industry payments across FL — which companies pay providers there.
